IONIS PHARMACEUTICALS INC ($IONS)

3 tracked superinvestors hold IONIS PHARMACEUTICALS INC (IONS), worth $1.3B combined, led by Steve Wymer. Smart money is holding IONS as of the latest 13F filings.

Current price

$64.27

BiotechnologyNASDAQUS

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial…

Market cap

$12.4B

P/E

-37.45

Div yield

0.0%

Revenue YoY

33.9%

Analyst target

$107

Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.

Superinvestors holding

3

tracked 13F / N-PORT funds

Combined value

$1.3B

disclosed long exposure

Tier-1 conviction

0

concentrated holders

Net this quarter

0

1 buying · 1 selling

Smart money is holding IONS steady this quarter — buys and sells are balanced.

The smart-money take on IONS

IONIS PHARMACEUTICALS INC (IONS) appears mainly in diversified and quant books here (3 funds, $1.3B combined) rather than in concentrated conviction portfolios — read the holders below with that in mind.

The largest position belongs to Steve Wymer at 0.9% of their book — no single tracked manager treats it as an outsized, top-weighted bet.

No tracked fund opened a new position this quarter; 1 added and 1 trimmed, a net add.

Superinvestors holding IONS

InvestorMove% of their portfolioPosition value
3
Steve Wymer

Fidelity Growth Company

Held0.9%$658M
2
Added0.4%$440M
3
Brian Berghuis

T. Rowe Price Mid-Cap Growth

Trimmed1.1%$207M

Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.

Frequently asked

Which superinvestors own IONS?

3 tracked funds hold IONIS PHARMACEUTICALS INC (IONS), the largest being Steve Wymer (Fidelity Growth Company) at 0.9% of its 13F portfolio. 0 of them are concentrated Tier-1 conviction managers.

Is smart money buying or selling IONS?

In the most recent 13F quarter, 1 tracked fund added or opened IONS and 1 trimmed it.

How much IONS do tracked funds hold?

Combined disclosed long exposure to IONS across tracked superinvestors is $1.3B as of the Mar 2026 filings.

Stocks often held alongside IONS

Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Mar 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.